Indices
S&P 500 1,548.71 -.84%
DJIA 13,984.80 -.77%
NASDAQ 2,780.05 -.91%
Russell 2000 829.36 -1.40%
Wilshire 5000 15,583.58 -.87%
Russell 1000 Growth 630.06 -.88%
Russell 1000 Value 861.87 -.78%
Morgan Stanley Consumer 745.48 -1.18%
Morgan Stanley Cyclical 1,078.60 -.95%
Morgan Stanley Technology 682.05 -.99%
Transports 4,888.99 -1.05%
Utilities 514.08 -1.02%
MSCI Emerging Markets 158.13 -.06%
Sentiment/Internals
Total Put/Call .80 +5.26%
NYSE Arms 1.18 +114.55%
Volatility(VIX) 19.25 +10.25%
ISE Sentiment 153.0 -6.71%
Futures Spot Prices
Crude Oil $86.29 +3.09%
Reformulated Gasoline 216.30 +3.74%
Natural Gas 7.46 +7.0%
Heating Oil 231.26 +2.95%
Gold 764.30 +1.39%
Base Metals 258.53 +1.76%
Copper 368.25 +.82%
Economy
10-year US Treasury Yield 4.68% unch.
US Dollar 78.08 -.17%%
CRB Index 338.15 +1.39%
Leading Sectors
Energy +1.0%
Biotech +.62%
Construction +.43%
Lagging Sectors
I-Banks -1.72%
REITs -2.14%
Homebuilders -2.75%
Evening Review
Market Performance Summary
WSJ Data Center
Sector Performance
ETF Performance
Style Performance
Commodity Movers
Market Wrap CNBC Video(bottom right)
S&P 500 Gallery View
Timely Economic Charts
GuruFocus.com
PM Market Call
After-hours Commentary
After-hours Movers
After-hours Stock Quote
In Play
Afternoon Recommendations
Oppenheimer:
- Rated (SXCI) Outperform, target $18.
Afternoon/Evening Headlines
Bloomberg:
-Saks Inc.(SKS) rose 3.7% after Women’s Wear Daily reported the luxury retailer was approached by at least one suitor in the past two weeks and may consider accepting an offer.
- Wilbur Ross, billionaire who specializes in resurrecting failed companies, is betting the US mortgage market will rise from the dead.
- Crude oil rose above $86/bbl. for the first time in NY on concern Turkish forces may pursue Kurdish militants in
- Warren Buffett’s Berkshire Hathaway(BRK/A), which has built a 17% stake in railroad Burlington Northern Santa Fe Corp.(BNI), lowered its holding of carriers Union Pacific(UNP) and Norfolk Southern(NSC).
- Genentech Inc.(DNA) said profit climbed 21%, fueled by sales of the cancer drugs Avastin and Rituxan. The stock declined $.81/share in extended trading to $76.69.
No comments:
Post a Comment